Ivenix Wins Medtech Breakthrough Award for
Best New Technology Solution in Drug Delivery

Ivenix Wins Medtech Breakthrough Award for Best New Technology Solution in Drug Delivery

By Susan Niemeier, MHA, BSN, RN, Chief Nursing Officer, Ivenix

We’re honored to have received the award for “Best New Drug Delivery Solution” by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology markets.

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including robotics, telehealth, mHealth, medical devices, and many more. This year’s program — the fourth annual awards — attracted more than 3,750 nominations from over 15 different countries throughout the world.

We’re particularly pleased to receive the award for “best drug delivery” because Ivenix was founded to make infusions safer. Many patients today don’t realize they’re at risk of infusion-related harm because of outdated technology in many legacy infusion pumps. Year after year, countless errors are reported to the FDA — some of these errors have been deadly, and many could have been prevented. And until now, infusion pumps have not experienced the change needed to significantly reduce infusion-related adverse events and meet the FDA’s new guidelines.

In developing our large-volume pump and infusion system, we tirelessly worked with industry and academic leaders to address the most pressing needs of infusion pumps and to set a new standard in infusion delivery. Ivenix’s infusion system was designed with a superior user interface with visual cues and step-by-step guidance for the delivery of fluids, medications and blood products. Onboard safeguards help reduce infusion errors by defaulting to the drug library and identifying incompatible and same medications on the pump. Furthermore, the drug library ensures that specific medications should be delivered on the correct line – primary or secondary or both.

The patented pumping technology focuses on delivering complex medications with measured flow that maximizes safety. It compensates for variability in height differential between the fluid container, the pump and the patient. The clinician no longer has to contend with the position of IV bags, the viscosity of the medication or movement of their patient to ensure accurate delivery. And, the use of bag hangers and back-check values are no longer required when delivering a secondary infusion (such as IV piggyback). The Ivenix infusion pump delivers exactly what is programmed (including overfill) on the secondary and automatically switches back to primary, aligning with the recommendations of ISMP and their 2020 Guidelines for Optimizing Safe Implementation and Use of Smart Infusion Pumps. The Ivenix pump also alerts when flow is obstructed on the secondary, such as a closed roller clamp, allowing the clinician to restore flow and avoid delays in therapy.

The Ivenix system offers unique line tracing, visual cues on the pump and administration set to help reduce the risk of line mix-ups. Fluids can be hung adjacent to these markings and LEDs to further reduce confusion. The cassette-based administration set is designed to simplify priming and loading. Clinicians don’t need to invert the cassette to remove air bubbles (to prime) or thread IV tubing through narrow channels to load. Gone are problematic roller clamps; instead say hello to the integrated flow dial within the administration set. The flow dial not only facilitates priming but it works in cooperation with the Ivenix pump to automatically close when an infusion is paused or stopped, effectively preventing the potential for free-flow conditions.

This award caps off an incredible 18 months for our team at Ivenix.  Last June, we received our FDA 510(k) clearance for our large-volume infusion pump and system, kicking off our commercialization efforts. And earlier in 2020, we were proud to announce a new leader at the helm as seasoned medtech leader Jorgen B. Hansen was named CEO. We’re looking forward to continuing this momentum in 2020 and to many exciting things yet to come.

For more information on how Ivenix can help cut through infusion complexity and put patients first, download our clinical brief.